CL monthly performance report
Monthly CL research: returns, drawdown, relative strength, seasonality, and key stats.
CL monthly report
—
Key takeaways
- Colgate-Palmolive (CL) closed September 2026 at $88.77, down 1.17% for the month and +6.10% over the trailing 12 months.
- Year-to-date, CL is +12.34%, underperforming the S&P 500 which has returned +12.94% YTD.
- The stock is trading +1.44% versus its 200-day moving average ($87.51), a bullish technical signal.
- Over the past three years, CL has underperformed the S&P 500 by −49.55%, with a relative strength index reading of 71.1.
- Win rate over the trailing 39 months stands at 56.4% — 22 positive months versus 17 negative months.
Colgate-Palmolive ended September 2026 at $88.77, posting a monthly return of −1.17%. The S&P 500 returned +0.41% over the same window, leaving relative performance at −1.58%.
The current quarter stands at −4.96% (Q3 2026 (QTD)), while medium-term trend remains constructive: price is +1.44% versus the 200-day moving average ($87.51).
Year-to-date, CL is +12.34% against SPY +12.94%, a gap of −0.61%. The stock is currently −10.63% below its 52-week high, with maximum 3-year drawdown at −31.07%.
| Period | CL | S&P 500 (SPY) | Excess return |
|---|---|---|---|
| 1 Day | −1.48% | +0.66% | −2.13% |
| 1 Week | −3.57% | −0.12% | −3.46% |
| 1 Month | −1.17% | +0.41% | −1.58% |
| 3 Months | +0.57% | +2.11% | −1.55% |
| 6 Months | −8.77% | +13.21% | −21.97% |
| YTD | +12.34% | +12.94% | −0.61% |
| 12 Months | +6.10% | +18.65% | −12.56% |
| 3 Years | +21.15% | +70.70% | −49.55% |
| Rank | Month | Return |
|---|---|---|
| #1 | Jan 2026 | +14.39% |
| #2 | Feb 2026 | +9.49% |
| #3 | Aug 2024 | +6.98% |
| #4 | Oct 2023 | +5.94% |
| #5 | Jan 2024 | +5.74% |
| Rank | Month | Return |
|---|---|---|
| #1 | Mar 2026 | −13.52% |
| #2 | Oct 2024 | −9.69% |
| #3 | Jul 2025 | −7.96% |
| #4 | Dec 2024 | −6.06% |
| #5 | Sep 2025 | −5.04% |
| Quarter | Return |
|---|---|
| Q2 2025 | −1.69% |
| Q3 2025 | −12.54% |
| Q4 2025 | −0.80% |
| Q1 2026 | +8.31% |
| Q2 2026 | +5.04% |
| Q3 2026 (QTD) | −4.96% |
| Year | Return |
|---|---|
| 2023 | +0.52% |
| 2024 | +14.81% |
| 2025 | −12.44% |
| 2026 | +8.12% |
| Metric | Value |
|---|---|
| 52-Week High | $99.33 (2026-02-27) |
| 52-Week Low | $74.55 (2025-11-03) |
| Current Price | $88.77 |
| 200-Day Moving Average | $87.51 |
| Price vs 200DMA | +1.44% |
| 3-Year Maximum Drawdown | −31.07% (2025-11-03) |
| Current Drawdown from 52W High | −10.63% |
| RS metric | Value |
|---|---|
| RS Index (3-year, rebased to 100) | 71.1 |
| 3-Year Excess Return vs S&P 500 | −49.55% |
| RS Peak | 123.2 (Sep 2024) |
| RS Trough | 67.7 (Nov 2025) |
| Status | Underperforming Benchmark |
Frequently asked questions
What was CL's return for this report period?
CL returned −1.17% in the latest monthly window ending 2026-09-04.
Has CL outperformed SPY year to date?
YTD CL: +12.34% vs SPY: +12.94%.
What is CL's 12-month return?
+6.10% over the trailing 12 months.
Is CL above or below its 200-day moving average?
Price is +1.44% versus 200DMA ($87.51).
What is the maximum drawdown in the 3-year window?
−31.07% on 2025-11-03.